Approval · Notice of Compliance 8282 · 2006
TYSABRI: Notice of Compliance 8282
Issued September 28, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8282
- Date
- September 28, 2006
- Company
- Biogen Idec Canada Inc
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Selective adhesion molecule inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TYSABRI | 02286386 | Marketed |
Medicinal ingredients
- NATALIZUMAB 300 MG per 15ML